Graffeo Christopher S, Kotecha Rupesh, Sahgal Arjun, Fariselli Laura, Gorgulho Alessandra, Levivier Marc, Ma Lijun, Paddick Ian, Regis Jean, Sheehan Jason P, Suh John H, Yomo Shoji, Pollock Bruce E
Department of Neurological Surgery, University of Oklahoma, Oklahoma City , Oklahoma , USA.
Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami , Florida , USA.
Neurosurgery. 2025 Feb 1;96(2):298-307. doi: 10.1227/neu.0000000000003102. Epub 2024 Jul 11.
Consensus guidelines do not exist to guide the role of stereotactic radiosurgery (SRS) in the management of patients with Spetzler-Martin Grade III-V arteriovenous malformations (AVMs). We sought to establish SRS practice guidelines for Grade III-V AVMs based on a critical systematic review of the published literature.
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant search of Medline, Embase, and Scopus, 1986 to 2023, for publications reporting post-SRS outcomes in ≥10 Grade III-V AVMs with the median follow-up ≥24 months was performed. Primary end points were AVM obliteration and post-SRS hemorrhage. Secondary end points included dosimetric variables, Spetzler-Martin parameters, and neurological outcome.
: In total, 2463 abstracts were screened, 196 manuscripts were reviewed, and 9 met the strict inclusion criteria. The overall sample of 1634 AVMs consisted of 1431 Grade III (88%), 186 Grade IV (11%), and 11 Grade V lesions (1%). Total median post-SRS follow-up was 53 months for Grade III and 43 months for Grade IV-V AVMs (ranges, 2-290; 12-262). For Grade III AVMs, the crude obliteration rate was 72%, and among Grade IV-V lesions, the crude obliteration rate was 46%. Post-SRS hemorrhage was observed in 7% of Grade III compared with 17% of Grade IV-V lesions. Major permanent deficits or death from hemorrhage or radiation-induced complications occurred in 86 Grade III (6%) and 22 Grade IV-V AVMs (12%).
Most patients with Spetzler-Martin Grade III AVMs have favorable SRS treatment outcomes; however, the obliteration rate for Grade IV-V AVMs is less than 50%. The available studies are heterogenous and lack nuanced, long-term, grade-specific outcomes.
目前尚无共识性指南来指导立体定向放射外科(SRS)在Spetzler-MartinⅢ-Ⅴ级动静脉畸形(AVM)患者管理中的作用。我们试图基于对已发表文献的批判性系统评价,制定Ⅲ-Ⅴ级AVM的SRS实践指南。
按照系统评价和Meta分析的首选报告项目规范,检索1986年至2023年的Medline、Embase和Scopus数据库,查找报告≥10例Ⅲ-Ⅴ级AVM患者SRS术后结局且中位随访时间≥24个月的文献。主要终点为AVM闭塞和SRS术后出血。次要终点包括剂量学变量、Spetzler-Martin参数和神经功能结局。
共筛选2463篇摘要,审阅196篇手稿,9篇符合严格纳入标准。1634例AVM的总体样本包括1431例Ⅲ级(88%)、186例Ⅳ级(11%)和11例Ⅴ级病变(1%)。Ⅲ级AVM的SRS术后总中位随访时间为53个月,Ⅳ-Ⅴ级AVM为43个月(范围分别为2 - 290个月;12 - 262个月)。对于Ⅲ级AVM,粗略闭塞率为72%,Ⅳ-Ⅴ级病变的粗略闭塞率为46%。Ⅲ级病变中7%发生SRS术后出血,Ⅳ-Ⅴ级病变中为17%。86例Ⅲ级(6%)和22例Ⅳ-Ⅴ级AVM(12%)因出血或放射性并发症出现严重永久性缺陷或死亡。
大多数Spetzler-MartinⅢ级AVM患者的SRS治疗结局良好;然而,Ⅳ-Ⅴ级AVM的闭塞率低于50%。现有研究存在异质性,缺乏细致的、长期的、分级特异性结局。